Green Fresh Biotechnology Co (HKSE:01084) Altman Z2-Score: 4.20 (As of Aug. 18, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01084 Green Fresh Biotechnology Co Ltd HKSE:01084
52 GF Score
Price HK$0.68
GF Value HK$0.55
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Green Fresh Biotechnology Co Altman Z2-Score?

Green Fresh Biotechnology Co HKSE:01084 -2.86% 52 Altman Z2-Score is 4.20 as of Aug. 18, 2026, which is 9% above its 10-year median of 3.85. GuruFocus rates HKSE:01084 with a GF Score™ of 52/100 and a GF Value™ of HK$0.55 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 1,898 Consumer Packaged Goods companies, Green Fresh Biotechnology Co ranks better than 55.22% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Green Fresh Biotechnology Co has a Altman Z2-Score of 4.20, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Green Fresh Biotechnology Co's Altman Z2-Score or its related term are showing as below:

HKSE:01084' s Altman Z2-Score Range Over the Past 10 Years
Min: 0.69   Med: 3.85   Max: 5
Current: 4.2

During the past 10 years, Green Fresh Biotechnology Co's highest Altman Z2-Score was 5.00. The lowest was 0.69. And the median was 3.85.


Green Fresh Biotechnology Co  (HKSE:01084) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Green Fresh Biotechnology Co Altman Z2-Score Related Terms


Green Fresh Biotechnology Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Green Fresh Biotechnology Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Fresh Biotechnology Co Altman Z2-Score Chart

Green Fresh Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.88 5.00 2.98 4.69 4.20

Green Fresh Biotechnology Co Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 0.00 4.69 0.00 4.20

HKSE:01084 vs ADM, BG, TSN: Altman Z2-Score Comparison

For the Farm Products subindustry, Green Fresh Biotechnology Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Fresh Biotechnology Co Altman Z2-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Green Fresh Biotechnology Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Green Fresh Biotechnology Co's Altman Z2-Score falls into.


HKSE:01084
52GF Score
Green Fresh Biotechnology Co Ltd HKSE:01084
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Green Fresh Biotechnology Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Green Fresh Biotechnology Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.276+3.26*0.344+6.72*0.0211+1.05*1.0681
=4.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was HK$1,803.2 Mil.
Total Current Assets was HK$1,230.1 Mil.
Total Current Liabilities was HK$732.4 Mil.
Retained Earnings was HK$620.4 Mil.
Pre-Tax Income was HK$7.9 Mil.
Interest Expense was HK$-30.2 Mil.
Total Liabilities was HK$867.4 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1230.077 - 732.42)/1803.245
=0.276

X2=Retained Earnings/Total Assets
=620.38/1803.245
=0.344

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(7.869 - -30.159)/1803.245
=0.0211

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(926.525 - 0)/867.428
=1.0681

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Green Fresh Biotechnology Co has a Altman Z2-Score of 4.20 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 4.20 mean?
Green Fresh Biotechnology Co (HKSE:01084) has a Altman Z2-Score of 4.20 as of Aug. 18, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Green Fresh Biotechnology Co and its competitors. This is near median its historical median of 3.85. Over the past decade, Green Fresh Biotechnology Co's Altman Z2-Score has ranged from 0.69 to 5.00. According to the industry distribution chart, Green Fresh Biotechnology Co ranks #850 out of 1898 companies in the Consumer Packaged Goods industry, placing it in the top 44.8%.
Is Green Fresh Biotechnology Co's Altman Z2-Score too high?
Green Fresh Biotechnology Co's current Altman Z2-Score of 4.20 is near median its 10-year median of 3.85. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 5.00. The Consumer Packaged Goods industry median Altman Z2-Score is 3.72. Green Fresh Biotechnology Co's value of 4.20 is 13.1% above this industry median. Based on the distribution chart, Green Fresh Biotechnology Co ranks #850 out of 1898 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Green Fresh Biotechnology Co has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Fresh Biotechnology Co's Altman Z2-Score compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Green Fresh Biotechnology Co ranks #850 out of 1898 companies for Altman Z2-Score. This puts Green Fresh Biotechnology Co in the upper half of its industry. The industry median Altman Z2-Score is 3.72. Green Fresh Biotechnology Co's value of 4.20 is 13.1% above this benchmark. Historically, Green Fresh Biotechnology Co's own Altman Z2-Score has ranged from 0.69 to 5.00 over the past decade. While the company's 10-year median is 3.85 vs. the industry median of 3.72, Green Fresh Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Consumer Packaged Goods company?
The median Altman Z2-Score among Consumer Packaged Goods companies is 3.72, based on 1,898 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Fresh Biotechnology Co's current Altman Z2-Score of 4.20 is 13.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Green Fresh Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Altman Z2-Score is 3.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Fresh Biotechnology Co's current Altman Z2-Score is 4.20, which is near median its own 10-year median of 3.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Fresh Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Green Fresh Biotechnology Co (HKSE:01084) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.55, compared to a current price of HK$0.68 — trading 23.6% above its estimated fair value. The current Altman Z2-Score is 4.20, which is near median its 10-year median of 3.85 and 13.1% above the Consumer Packaged Goods industry median of 3.72. Green Fresh Biotechnology Co's overall GF Score™ is 52/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Green Fresh Biotechnology Co (HKSE:01084), the current Altman Z2-Score is 4.20 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Green Fresh Biotechnology Co (HKSE:01084) Overvalued in 2026?

Based on GuruFocus' analysis, Green Fresh Biotechnology Co stock appears to be overvalued. The current stock price of HK$0.68 is trading 23.6% above its estimated GF Value™ of HK$0.55. GuruFocus considers Green Fresh Biotechnology Co to be Modestly Overvalued.

Key valuation signals for HKSE:01084:

  • Altman Z2-Score: 4.20 (near median its 10-year median of 3.85)
  • GF Value™: HK$0.55 vs. price of HK$0.68 (23.6% above fair value)
  • GF Score™: 52/100 with 10 warning signs
  • Industry Position: 13.1% above the Consumer Packaged Goods median (#850 of 1898)

No single metric tells the full story. See the HKSE:01084 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Green Fresh Biotechnology Co Business Description

Address 169 Electric Road, Flat A, 16th Floor, North Point, Hong Kong, HKG
Green Fresh Biotechnology Co Ltd, formerly Green Future Food Hydrocolloid Marine Science Co Ltd is engaged in manufacturing and sales of food manufacturing hydrocolloid products including carrageenan products, agar-agar products, blended products, and konjac products in the People's Republic of China and overseas. Its segments include Manufacturing and sales of agar-agar products, which derives maximum revenue; Manufacturing and sales of carrageenan; Manufacturing and sales of konjac products; Manufacturing and sales of blended products; and Others, such as trading of seaweed powder and other operations. Its operations are spread across Chinese Mainland, which derives maximum revenue; Europe; Asia (excluding Chinese Mainland); South America; North America; Africa; and Oceania.
52GF Score

Get the complete analysis for HKSE:01084

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.68
Price
HK$0.55
GF Value